KMI
73
4
PFE
33
-2
NWS
75
6
DOW
47
3
PCG
66
5
UPS
53
3
TXT
48
2
AEP
43
-4
DNB
56
2
PVH
62
4
TXN
35
5
GD
44
2
BMY
33
-2
GS
58
5
NUE
41
2
ADM
27
2
WAT
59
4
HST
57
4
CFG
40
4
CL
50
3
KMI
73
4
PFE
33
-2
NWS
75
6
DOW
47
3
PCG
66
5
UPS
53
3
TXT
48
2
AEP
43
-4
DNB
56
2
PVH
62
4
TXN
35
5
GD
44
2
BMY
33
-2
GS
58
5
NUE
41
2
ADM
27
2
WAT
59
4
HST
57
4
CFG
40
4
CL
50
3
Financhill
Back

Heron Therapeutics 10K Form

Sell
32

HRTX
Heron Therapeutics

Last Price:
$1.60
Seasonality Move:
11.9%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive HRTX News And Ratings

See the #1 stock for the next 7 days that we like better than HRTX

HRTX Financial Statistics

Sales & Book Value

Annual Sales: $127M
Cash Flow: $2.9M
Price / Cash Flow: 0
Annual Sales: $-0.26
Price / Book: 0

Profitability

EPS (TTM): -0.16000
Net Income (TTM): $-28M
Gross Margin: $61.9M
Return on Equity: 0%
Return on Assets: -12.62%

Heron Therapeutics Earnings Forecast

Key Heron Therapeutics Financial Ratios

  • The Gross Profit Margin over the past 37 years for HRTX is 48.75%.
  • The Selling, General & Administrative Expenses for HRTX have been equal to 91.82% of Gross Profit Margin.
  • The Research & Development expenses have been 44.00% of Revenue.
  • The Interest Expense is -3.50% of Operating Income.
  • The Net Earning history of HRTX is -87.02% of Total Revenues.
  • Per Share Earnings over the last 37 years have been positive in 20 years.

Heron Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: HRTX
CUSIP: 427746
Website: herontx.com

Debt

Debt-to-Equity Ratio: -4.36
Current Ratio: 2.28
Quick Ratio: 1.61

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

HRTX Technical Analysis vs Fundamental Analysis

Sell
32
Heron Therapeutics (HRTX) is a Sell

Is Heron Therapeutics a Buy or a Sell?